ID
15372
Beschrijving
Study documentation part: Relapse Evaluation Study short name: DIMAT MS Study Details: A 24-week, multicenter, exploratory, two arm study to assess the effect of Dimethyl fumarate on ImmuneModulatory Action on T cells in patients with relapsing remitting Multiple Sclerosis. Principal Investigator PD Dr. Luisa Klotz, University Hospital Münster EudraCT - No.: 2014-003481-25. Clinical Trial No.r: NCT02461069. Please document clinically significant symptoms as Adverse Events on form Adverse Events. (and also additionally as SAE if a seriousness criterion is fulfilled). Please document all Medications which are administered to treat the relapse on form concomitant medication. Please document all Study Medication dose adjustments and interruptions on form study medication.
Trefwoorden
Versies (4)
- 17-11-15 17-11-15 - Julian Varghese
- 17-11-15 17-11-15 - Julian Varghese
- 28-05-16 28-05-16 -
- 28-05-16 28-05-16 -
Geüploaded op
28 mei 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Relapse Evaluation DIMAT-MS, Relapsing Remitting Multiple Sclerosis DRKS00008037 NCT02461069
Relapse Evaluation DIMAT-MS, Relapsing Remitting Multiple Sclerosis NCT02461069Relapse Evaluation
Beschrijving
Treatment of Relapse
Beschrijving
no treatment
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0035020
- UMLS CUI [1,2]
- C0332155
Beschrijving
Plasmapheresis / Immunoadsorption
Datatype
boolean
Alias
- UMLS CUI [1]
- C0398341
- UMLS CUI [2]
- C0032134
Beschrijving
enter number of cycles
Datatype
integer
Beschrijving
other treatment
Datatype
text
Alias
- UMLS CUI [1]
- C0087111
Beschrijving
Intravenous Steroid Treatment
Alias
- UMLS CUI-1
- C0149783
Beschrijving
Signature
Similar models
Relapse Evaluation DIMAT-MS, Relapsing Remitting Multiple Sclerosis NCT02461069Relapse Evaluation
C0808070 (UMLS CUI [1,2])
C0521091 (UMLS CUI [1,2])
C0521091 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0332155 (UMLS CUI [1,2])
C0032134 (UMLS CUI [2])
C0011008 (UMLS CUI [1,2])